Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?

Eur Respir J. 2015 Sep;46(3):846-9. doi: 10.1183/09031936.00237014. Epub 2015 Apr 16.

Authors

Andriana I Papaioannou¹, Konstantinos Bartziokas², Stelios Loukides³, Stamatoula Tsikrika¹, Foteini Karakontaki¹, Aikaterini Haniotou², Spyros Papiris³, Daiana Stolz⁴, Konstantinos Kostikas⁵

Affiliations

¹ 3rd Respiratory Medicine Dept, Sismanogleion General Hospital, Athens, Greece.
² Respiratory Medicine Dept, Amalia Fleming Hospital, Athens, Greece.
³ 2nd Respiratory Medicine Dept, University of Athens Medical School, Athens, Greece.
⁴ Respiratory Medicine Dept, University Hospital, Basel, Switzerland.
⁵ 2nd Respiratory Medicine Dept, University of Athens Medical School, Athens, Greece [email protected].

PMID: 25882807
DOI: 10.1183/09031936.00237014

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology*
Cardiovascular Diseases / therapy
Case-Control Studies
Comorbidity
Diabetes Mellitus / diagnosis
Diabetes Mellitus / epidemiology
Diabetes Mellitus / therapy
Female
Forecasting
Hospital Mortality*
Hospitalization / statistics & numerical data*
Humans
Hypertension / diagnosis
Hypertension / epidemiology
Hypertension / therapy
Male
Predictive Value of Tests
Prognosis
Pulmonary Disease, Chronic Obstructive / diagnosis
Pulmonary Disease, Chronic Obstructive / epidemiology*
Pulmonary Disease, Chronic Obstructive / therapy
Retrospective Studies
Risk Assessment
Severity of Illness Index
Survival Analysis